ABERRANT N-GLYCOSYLATION REGULATES INVASION OF MG-63 CELLS THROUGH EXTRACELLULAR MATRIX REMODELING by MUSTAFA, SARMILA HANIM et al.
International Journal of Applied Pharmaceutics
ISSN - 0975 - 7058 Vol 11, Special Issue 5, 2019
ABERRANT N-GLYCOSYLATION REGULATES INVASION OF MG-63 CELLS THROUGH 
EXTRACELLULAR MATRIX REMODELING
SARMILA HANIM MUSTAFA1,2, MUDIANA MUHAMAD2*, SHARANIZA AB-RAHIM2
1Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Institute of Medical and Molecular Biotechnology, Universiti 
Teknologi MARA, Cawangan Selangor, Kampus Sungai Buloh, 47000 Sungai Buloh, Selangor, Malaysia. 2Department of Biochemistry and 
Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, Cawangan Selangor, Kampus Sungai Buloh, 47000 Sungai Buloh, 
Selangor, Malaysia. Email: mudiana_muhamad@salam.uitm.edu.my
Received: 24 January 2019, Revised and Accepted: 25 July 2019
ABSTRACT
Objective: Despite advances in multimodal therapy, osteosarcoma (OS) still imposes big challenge due to its high rate of metastasis. The previous 
studies reported that aberrant glycosylation in the cells mediates the invasion of several cancers including OS. However, its mechanism, particularly 
N-glycosylation in OS progression, is still poorly understood. Thus, this study aims to investigate the effect of glycosylation inhibitions toward OS cells 
invasiveness.
Materials and Methods: Both 1-deoxynojirimycin (DNJ) and 1-deoxymannojirimycin (1-DMJ) were used to inhibit the activities of 
alpha-glucosidase-I/II and alpha-1,2-mannosidase, respectively. Invasion assay and real-time polymerase chain reaction (PCR) (quantitative PCR 
[qPCR]) analysis of extracellular matrix-related genes were performed at post 24 h of treatment with the inhibitors, 0.5 mM 1-DNJ and 0.5 mM 1-DMJ, 
respectively, on the OS cell line, MG-63.
Results: Results showed that the inhibition of N-glycosylation with 1-DNJ decreases the invasion rate of MG-63 cells while the inhibition of 
N-glycosylation by 1-DMJ caused the invasion rate of MG-63 cells to increase. qPCR analysis showed downregulated expression of matrix 
metalloproteinase (MMP2) gene in both types of treatments while the expression of its inhibitor, tissue inhibitor of metalloproteinase (TIMP2) was 
upregulated in both types of treatments. In this study, MMP9 genes were not detected in both samples; however, the expression of its inhibitor, TIMP1 
was downregulated in MG-63 cells treated with 1-DNJ but upregulated in 1-DMJ treated cells.
Conclusion: It is concluded that 1-DNJ reduced the invasion rate in MG-63 cells through downregulation of MMP2 gene which subsequently reduced 
degradation of collagen type IV. However, the contrasting effect showed by 1-DMJ requires further investigation to elucidate its underlying mechanism.
Keywords: Extracellular matrix genes, Glycosylation inhibitors, N-glycosylation, Osteosarcoma.
INTRODUCTION
Osteosarcoma (OS) is a primary malignant bone tumor that has bimodal 
age distribution with the first peak of invasion occurs on children 
and adolescence between the ages of 10 and 20 years old, and the 
second peak of invasion occurs after 65 years of age [1]. Although OS 
incidences are rare, OS has been reported as the most common primary 
malignant bone tumor (36%) followed by chondrosarcoma (20-25%) 
and Ewing sarcoma (16%) [2,3] and it has been pre-dominated by 
male with the ratio of 1.6–1.7:1 [4]. To date, the current therapeutic 
strategies are still unable to provide promising long-term OS prognosis, 
whereby over 40% of patients experience relapsed and 20% of patients 
were diagnosed with metastatic OS [5]. Thus, it is important to explore 
the OS metastasis mechanism for better understanding of the disease 
progression.
Cancer invasion starts with activation of signalling pathways that 
regulate the cytoskeletal formation together with the cell-extracellular 
matrix (ECM) and cell–cell interactions which results in variation 
of adhesion strength. Subsequently, tumor cells will start to migrate 
and formed angiogenesis [6,7]. Integrin, a receptor for fibronectin 
is the primary receptor involved in the cell–cell and cell-ECM 
interaction [8,9]. Furthermore, integrin has been shown to be involved 
in cancer cells through malignancy. The binding of integrin to the 
ECM proteins is largely influenced by the glycosylation of the integrin 
itself, whereby most integrin are highly glycosylated and were found 
to be overexpressed in cancer cells, thus suggested as a cause for 
metastasis [9]. Moreover, aberrant integrin glycosylation possibly leads 
to alteration of the adhesion properties of integrin to the ECM, resulting 
in increased capacity of tumor cells to invade nearby cells [9]. To date, 
the most described glycosylation alterations are the accumulation of 
high mannose [10] and premature termination of glycan processing, 
synthesis of highly branched glycans [11], decreased in bisecting 
glycans, and increased of terminal modification such as sialylation and 
fucosylation [12,13].
While aberrant glycosylation is responsible for cancer progression, 
uncontrolled ECM remodeling also contributes to increased 
malignancy of cancer cells [14]. The degradation of ECM during 
remodeling process is associated with the upregulation of matrix 
metalloproteinases (MMPs) expression as found in most metastasis 
cases [15,16]. The expression level of MMPs by normal and cancer cells 
is different, suggesting its effect on the environment subsequently 
regulating cancer cell progression [17]. Both MMP2 and MMP9 
are gelatinase that cleaves collagen type IV, the main component of 
ECM and the activity of both MMP2 and MMP9 are regulated by the 
coexpression of their respective tissue inhibitor of metalloproteinases 
(TIMPs) [14-17].
Although associations of cells and ECM are well documented in many 
cancer cells progression, there is still lack of study on OS metastasis. 
Therefore, this study aims to investigate the role of N-glycosylation in 
the OS cells through ECM dysregulation.
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MATERIALS AND METHODS
Cell culture
The MG-63 human OS cell was purchased from the American 
Type Culture Collection (ATCC, USA) and was maintained in 1:1 mixture 
of Ham’s 12 Medium Dulbecco’s Modified Eagle’s Medium, with 2.5 mM 
L-glutamine (Nacalai Tesque, JPN). The medium was supplemented 
with 10% fetal bovine serum (FBS; Gibco, Life Technologies, CA), 
100 U/ml of penicillin, 100 µg/ml of streptomycin, and 0.25 µg/ml of 
amphotericin B (Gibco, Life Technologies, CA) at 37°C in a humidified 
incubator with the presence of 5% CO2.
Glycosylation inhibition assay
The 1-deoxynojirimycin (1-DNJ) and 1-deoxymannojirimycin (1-DMJ) 
were purchased from Cayman Chemical (Cayman Chemical, USA). 
The in vitro cytotoxicity analysis was carried out on the glycosylation 
inhibitors to determine the optimum concentration and incubation 
time to MG-63 cells since these compounds were dissolved in dimethyl 
sulfoxide (1 mg/ml). Briefly, the cells were seeded at a density of 
1×105 cells/well in a 96-well plate and incubated for 24 h at 37°C 
in a humidified incubator with the presence of 5% CO2. At post 24 h 
incubation, the media were discarded and replaced with 100 µL of 
treatment media containing six different concentrations (0.25, 0.5, 1, 2, 
and 3 mM) of 1-DNJ and 1-DMJ. The cells were further incubated for 6, 
12, 18, 24, and 48 h at 37°C in a humidified incubator with the presence 
of 5% CO2. The non-treated cells were assigned as the control group.
The cell viability was determined using the CellTiter 96® AQueous 
One Solution Cell Proliferation (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium [MTS]) 
colorimetric assay (Promega, USA) according to the manufacturer 
protocol. The effects of both 1-DMJ and 1-DNJ on the growth 
of MG-63 cells were measured by adding 20 µl of MTS solution to 
each well without discarding the treatment media. Then, the plate 
was incubated at 37°C in a humidified incubator with the presence of 
5% CO2 for 1 h. The colorimetric changes were measured by reading 
the absorbance at 490 nm using VICTOR multilabel plate reader 
(PerkinElmer, USA).
Cell invasion assay
The cell invasion assay was performed using the Chemicon QCM 96-well 
Cell Invasion Assay Kit (Millipore, USA) according to the manufacturer 
protocol. Briefly, a cell density of 1×106 cells/well was prepared before 
invasion assay. The cells were incubated with 1-DNJ and 1-DMJ at 
0.5 mM without the presence of serum for 24 h at 37°C in a humidified 
incubator with the presence of 5% CO2. At post 24 h of incubation, the 
cells were detached using 2 mM EDTA/PBS solution and resuspended in 
the serum-free culture media containing 5% of bovine serum albumin. 
Then, 1×105 cell/well was added to the invasion chamber and allowed to 
invade the ECMatrix® coated membrane for 24 h. Invaded cells attached 
to the bottom of the membrane were dissociated by incubation with 
150 µl/well of cell detachment solution (supplied by the kit) for 30 min 
at 37°C in a humidified incubator with the presence of 5% CO2. Next, 
50 µl/well of lysis buffer/CyQuant GR Dye solution (1:75) was added 
for another incubation at room temperature. Finally, 150 µl of the cell 
mixture was transferred to a new black 96-well plate for fluorescence 
measurement. The fluorescent value was detected by Infinite 200 PRO 
NanoQuant Microplate Reader (Tecan, Switzerland) using 480/520 nm 
filter set and gained setting of 65.
Extraction of total cellular RNA
Total cellular RNA was extracted from MG-63 cells (control and post-
treated) using the RNeasy Mini Kit (QIAGEN, Germany) according 
to the manufacturer protocol. Approximately 1×106 cells were lysed 
using 350 µl of lysis buffer. Then, the cells were homogenized using 
QIAshredder (QIAGEN, USA) and centrifuged at 14,500 rpm for 2 min. 
Subsequently, one volume of 70% ice-cold ethanol was added into 
the lysate and mix well. Next, 700 µl of all the lysate were transferred 
to the spin column and centrifuged 15 s at 12000 rpm. After the 
centrifugation, the flow through was discarded and the cells were 
washed with 700 µl of washing buffer, centrifuged at 12,000 rpm for 
15 s. After the centrifugation, again the flow through was discarded and 
the spin column was added with 500 µl of mild washing buffer (with the 
addition of absolute ethanol) and centrifuged at 12,000 rpm for 15 s. 
Next, as the flow through was discarded, 500 µl of the same washing 
buffer was added again into the column and centrifuged at 12,000 rpm 
for 2 min. The spin column was dried by centrifugation at 14,500 rpm 
for 1 min. Finally, 30 µl of RNase-free water were added directly to the 
membrane of spin column and centrifuged at 12,000 rpm for 1 min to 
elute the RNA. The RNA was stored at −20°C until further used. The 
purity and concentration of the extracted RNA were determined by 
RNA gel electrophoresis and NanoDrop ND-100 spectrometer (data not 
shown).
cDNA synthesis and quantitative real-time polymerase chain 
reaction (PCR)
Approximately 5 µg of the extracted RNA was reverse transcribed 
using QuantiNova Reverse Transcription (RT) Kit (QIAGEN, Germany) 
according to manufacturer protocol. The RT reaction mixture was 
consisted of gDNA removal mix (0.1 µl/1 µl reaction), RT enzyme 
(0.05 µl/1 µl reaction), RT mix (0.2 µl/1 µl reaction), RNase-free 
water, and RNA templates. The cDNA synthesis was carried out in the 
Eppendorf Mastercycler® Pro Thermal Cycler (Eppendorf, Germany) 
with the program of 25°C for 3 min, 45°C for 10 min, and 85°C for 5 min. 
The cDNA template was diluted 1:10 with RNase-free water for real-
time PCR application.
The amplification of cDNA for each target genes (MMP2, MMP9, TIMP2, 
and TIMP1) and reference genes (GAPDH, 18SRNA, and β-actin) was 
done using the QuantiNova SYBR-Green PCR Kit (QIAGEN, USA) using 
their specific primers (Table 1). The amplification profile involved PCR 
heat activation step at 95°C for 2 min and 40 cycles of denaturation 
at 95°C for 5 s, and two-step of annealing and extension at 60°C for 
10 s. The amplification was carried out in the CFX96z® real-time PCR 
Detection System (Bio-Rad, USA).
Table 1 lists all the primers used in this study specific to each type of 
gene. The primer was designed using National Center for Biotechnology 
Information primer design tool and has been checked for specificity 
using Primer-BLAST.
Table 1: List of primers and its forward and reverse sequence









MMP: Matrix metalloproteinase, TIMP: Tissue inhibitor of metalloproteinase
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Statistical analysis
Glycosylation inhibition assay was repeated 3 times and was done in 
triplicate for each time. The significance of the data was evaluated by 
one-way ANOVA test using the SPSS statistical software. Invasion assay 
and RT-quantitative PCR (qPCR) were repeated 3 times and were done 
in triplicate for each time. The significance of the data was evaluated 
by t-test Statistical Package for the Social Sciences (SPSS) statistical 
software (version 23.0; SPSS, Inc., Chicago, USA). p<0.05 indicated a 
statistically significant differences across the data.
RESULTS
Glycosylation inhibition assay
The optimum concentration of inhibitors in MG-63 cells was 
determined before the cytotoxicity analysis of the compound. The cell 
viability plot against different incubation times for both glycosylation 
inhibitors, 1-DNJ (Fig. 1a) and 1-DMJ (Fig. 1b) revealed that the 
optimum concentration for both inhibitors was 0.5 mM with the 
optimal incubation time of 24 h. Thus, this dose and incubation time 
was used throughout this study.
Cell invasion assay
Results showed that inhibition with 0.5 mM of 1-DNJ for 24 h decreased 
the invasion rate in MG-63 cells by 0.62-fold while inhibition with 
0.5 mM 1-DMJ for 24 h increased the invasion rate of MG-63 cells 
by 3.87-fold (Fig. 2).
Expression of MMP2, MMP9, TIMP2, and TIMP1 genes
The RT-qPCR analysis showed that the expression level of MMP2 gene 
was decreased in 1-DNJ and 1-DMJ by 0.8-fold and 0.1-fold, respectively, 
while the expression of its suppressor gene, TIMP2 was increased in 
1-DNJ and 1-DMJ by 1.22-fold and 1.43-fold, respectively. In this study, 
MMP9 gene was not detected at all in both treatments; however, the 
expression of its inhibitor, TIMP1 was decreased in 1-DNJ by 0.24-fold 
and increased in 1-DMJ by 1-fold (Fig. 3).
DISCUSSION
The endoplasmic reticulum (ER) serves as the maturation site for 
one-third of the total proteins synthesized in the eukaryotic cells [18]. 
The fate of a newly synthesized polypeptide is defined by its folding 
degree in the ER and this process requires assistances to ensure the 
folding efficiency [19]. The N-glycosylation process; the removal 
of terminal glucose and mannose residues from protein-bound 
oligosaccharides and the addition of specific glucose residues controls 
the sequential events of the ER quality controls [20,21].
In this study, the effect of aberrant glycosylation was demonstrated 
on cell invasion assay and analysis of matrix in responsible for ECM 
degradation. This was done by inhibiting the glycosylation process 
with 1-DNJ and 1-DMJ; a specific inhibitor of α-glucosidase-I and II and 
Class I α-1,2-mannosidase, respectively.
The N-glycan has a core structure of Glc3Man9GlcNAc2. On entering 
the ER lumen for processing, the sequential events of α-glucosidase-I 
and II will hydrolyze a total of three glucose residues during the 
N-glycan processing [19].
As the cells were treated with α-glucosidase-I and II inhibitor (1-DNJ), 
the trimming process will be halted, thus releasing the tagged proteins 
from the calnexin (CNX) and calreticulin (CRT) which are the lectin 
chaperons. As the protein was not targeted either for degradation or 
folding enhancement, this misfolded protein will be released to the Golgi 
and said to have undergone aberrant glycosylation. However, a process 
catalyzes by uridine diphosphate glucuronosyltransferase 1 may allow 
the rerecognition of N-glycans by CNX/CRT by adding one glucose 
residue to the core unit, thus giving the opportunity to the protein to fold 
correctly and leave the ER [21]. Thus, the effect of 1-DNJ in the invasion 
rate of OS cells showed a correlation with the inhibition effect of 1-DNJ 
in the glycosylation process. Similar inhibitor was used in the previous 
study by Wang et al.; 1-DNJ has been shown to have antimetastatic 
effects on melanoma B16F10 cells. Incubation of B16F10 cells with 
1-DNJ decreased the cells adhesion, migration, and invasion [22].
Class 1 α-1,2-mannosidase specifically hydrolyzes mannose residues 
with α-1,2 linkage from the core structure in the ER generating 
Man5GlcNAc2 [23]. The mannose trimming process in the ER has 
been suggested to be as regulatory factor timer that determines the 
folding and degradation of a protein [23]. Inhibition of Class 1 α-1,2-
mannosidase by 1-DMJ will disrupt the mannose trimming process, 
thus cause an accumulation of N-glycans with high-mannose content 
which is one of the most alteration found in cancer cells [11,24]. This 
inhibition mechanism was in line with the invasion assay results of 
1-DMJ that showed increase invasion rate of OS cells.
Fig. 2: Rate of invasion in MG-63 cells treated with 
1-deoxynojirimycin (DNJ) and 1-deoxymannojirimycin (DMJ). The 
cells were harvested for invasion assay at post 24 h of treatment. 
1-DNJ decreased the rate of invasion by 0.62-fold while 1-DMJ 
showed an increase of 3.87-fold in relative to control (*p<0.05)
Fig. 1: Screening for optimum concentration of 
1-deoxynojirimycin (DNJ) and 1-deoxymannojirimycin (DMJ) 
for treatment in MG-63 cells. (a) The chosen concentration for 
1-DNJ was 0.5 mM due to high viability percentage of 77.7–87.4% 
throughout all incubation time. (b) The chosen concentration for 
1-DMJ was 0.5 mM due to high viability percentage of 71–93.2% 
throughout all incubation time (*p<0.05)
a
b
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MMP2 and MMP9 are the gelatinase that is responsible for the 
degradation of collagen type IV. The activity of MMPs may be regulated 
either by proenzyme activation or the inhibitory effects of their natural 
inhibitors which provide negative control on the MMPs activity [15,16]. 
TIMP2 has been reported to inhibit the activity off MMP2 while TIMP1 
may inhibit the activity of MMP9 [17]. To investigate the association 
between N-glycosylation inhibition in OS cells and ECM regulation, the 
expression of MMP2, MMP9, TIMP1, and TIMP2 was analyzed.
In this study, the downregulation of MMP2 and the upregulation 
of TIMP2 genes in 1-DNJ treated cells correlate with the decreased 
invasion rate of OS cells. This is attributable to the upregulation of 
TIMP2 genes, which is a suppressor gene for MMP2. This result is in 
line with the results obtained previously on the correlation between 
MMPs activity and invasion rate. The study reported that the inhibition 
of the migration and invasion of hepatocellular carcinoma cells (HCC) 
observed with the downregulation of MMP2 expression [25]. Another 
study revealed that the inhibition of MMP2 activities decreases the 
migration and angiogenesis of retinoblastoma cells [26].
However, contrast result was obtained between MMP2 and TIMP2 
gene expression level in MG-63 cells treated with 1-DMJ. Instead of 
upregulation of MMP2 and MMP9 genes in correlation with the increase 
invasion rate in MG-63 treated with 1-DMJ, the expression for MMP2 
was downregulated and no signals of MMP9 were obtained from the 
RT-qPCR of both genes. The increase of invasion rate in MG-63 treated 
with 1-DMJ could be due to 1-DMJ activity that gives direct effect to 
TIMPs that later regulating the activity of both MMPs. This is because 
TIMP1 and TIMP2 have been reported to exhibit antiapoptotic activity, 
thus causing the cells to proliferate more [27].
Moreover, since MMP2 and MMP9 are both secretory enzymes, the 
expression of total RNA may not demonstrate the actual activities of the 
proteins. For qPCR analysis of ECM-related genes, only 1-DNJ showed 
correlation between MMP2/TIMP2 expression and decrease invasion 
of OS cells. Thus, further study will be performed to elucidate the 
mechanism of action underlying the glycosylation inhibitory effects of 
1-DNJ and 1-DMJ on cancer metastasis.
CONCLUSION
It is concluded that 1-DNJ reduced the invasion rate in MG-63 cells 
through downregulation of MMP2 gene which subsequently reduced 
degradation of collagen type IV. However, the contrasting effect showed 
by 1-DMJ requires further investigation to elucidate its underlying 
mechanism.
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